Dr. Hong Liu-Seifert

Dr. Hong Liu-Seifert
Statistical Consultant at Lilly
 
Biography
Dr. Hong Liu-Seifert, Ph.D., is a research advisor for the Alzheimer’s Disease Global Development Team at Eli Lilly and Company. She earned her doctorate degree in statistics from Tulane University in 2001 and upon graduation joined Lilly. She has worked on multiple major neuroscience compounds contributing to the regulatory and commercialization success of these assets. Currently she is the group leader of the statistical function supporting clinical research efforts for investigational treatments for Alzheimer’s disease. Dr. Liu-Seifert’s main research interest is to apply innovative statistical methodologies to the research and development of neuroscience treatments, in particular Alzheimer’s disease. She has published 40 manuscripts in peer-reviewed scientific journals and has presented her work at numerous national and international conferences. Dr. Liu-Seifert serves on multiple Editorial Boards for scientific journals.
 
Research Interest
Dr. Hong Liu-Seifert, Ph.D., is a research advisor for the Alzheimer’s Disease Global Development Team at Eli Lilly and Company. She earned her doctorate degree in statistics from Tulane University in 2001 and upon graduation joined Lilly. She has worked on multiple major neuroscience compounds contributing to the regulatory and commercialization success of these assets. Currently she is the group leader of the statistical function supporting clinical research efforts for investigational treatments for Alzheimer’s disease. Dr. Liu-Seifert’s main research interest is to apply innovative statistical methodologies to the research and development of neuroscience treatments, in particular Alzheimer’s disease. She has published 40 manuscripts in peer-reviewed scientific journals and has presented her work at numerous national and international conferences. Dr. Liu-Seifert serves on multiple Editorial Boards for scientific journals.
 

Relevant Conferences